Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) FCF Margin (2016 - 2025)

Historic FCF Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 2.08%.

  • Nephros' FCF Margin rose 197900.0% to 2.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.12%, marking a year-over-year increase of 303900.0%. This contributed to the annual value of 3.92% for FY2024, which is 92000.0% down from last year.
  • Latest data reveals that Nephros reported FCF Margin of 2.08% as of Q3 2025, which was up 197900.0% from 22.49% recorded in Q2 2025.
  • Nephros' FCF Margin's 5-year high stood at 33.49% during Q4 2024, with a 5-year trough of 84.81% in Q1 2022.
  • Moreover, its 5-year median value for FCF Margin was 7.06% (2022), whereas its average is 8.58%.
  • As far as peak fluctuations go, Nephros' FCF Margin skyrocketed by 1039000bps in 2021, and later tumbled by -819600bps in 2022.
  • Over the past 5 years, Nephros' FCF Margin (Quarter) stood at 12.35% in 2021, then soared by 38bps to 7.62% in 2022, then fell by -10bps to 8.39% in 2023, then surged by 499bps to 33.49% in 2024, then tumbled by -94bps to 2.08% in 2025.
  • Its last three reported values are 2.08% in Q3 2025, 22.49% for Q2 2025, and 6.6% during Q1 2025.